The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
What's New at
  • Email Email
  • Glossary Glossary


You Say Whore Like It's a Bad Thing

Enid Vázquez, Test Positive Aware Network; Posted Aug 28, 3:12 p.m. ET

The communities most at risk for HIV are often communities with the most stigma around their sex lives. How can we make that connection more apparent?

Making Good on the Promise of PrEP

Kellee Terrell, Test Positive Aware Network; Posted Aug 28, 3:11 p.m. ET

If you look at Jim Pickett's 20-year career, it's hard to believe that this wasn't his intended path.

Hepatitis C Transmission and Prevention

Roger Pebody,; Posted Aug 28, 3:06 p.m. ET

We don't yet have a vaccine to prevent hepatitis C. In the meantime, here's how to prevent transmission.

Hepatitis C: Meet the Meds

Roger Pebody,; Posted Aug 28, 3:04 p.m. ET

Hepatitis C treatment used to last up to a year, and didn't wipe out the virus in everyone. Meet the current generation of pill-only treatments that can achicve a cure for many in just 12 weeks.

Share Your Stories!

Everyone living with HIV has a story to tell. Find out how to share your own experiences in one or both of the series below, which feature the writings of readers like you.

Day One With HIV: Finding Out Your Status, in Your Own Words

Regardless of where or how it happened, the day you received your HIV-positive diagnosis was likely among the most intense days you'll ever live through. Some of's readers have generously shared their experiences -- to reflect on how they've changed, and so that others would know that they too can survive, and even thrive, following that fateful day. How did you get through it?

Other Sides of HIV: People Taking HIV Meds Share Stories About Side Effects

Many types of medications can save or improve lives, but they can also have unintended consequences. For some people living with HIV, taking meds can be a complicated cycle -- and for others, a Sunday stroll. Medication side effects can be mild or life altering, horrible or even pleasurable; some people living with HIV never experience any at all. It seems like everyone's got a story about side effects. What's yours?


How Injustice Politicized Early AIDS Activists

Maia Paroginog, Visual AIDS; Posted Aug 28, 1:46 p.m. ET

In this interview with the director of HBO's Larry Kramer in Love & Anger, the director goes into the anger and frustration that fuels some of the epidemic's most memorable activism.

Carl Dieffenbach on U.S. Government Support for HIV Cure Research (Video)

Barbara Jungwirth,; Posted Aug 28, 1:03 p.m. ET

According to Carl W. Dieffenbach, Ph.D., director of the Division of AIDS at the U.S. National Institute of Allergy and Infectious Diseases, the government is a "funder of fundamental science" so a proof of concept of an HIV cure can be achieved. "Industry will then know what to do" with that concept, he continued. Topics that research needs to address include the role of broadly neutralizing monoclonal antibodies in fighting HIV and the role the viral reservoir plays in the replication of HIV -- knowledge gaps that must be addressed by "the best and the brightest" across medical disciplines.

Dázon Dixon Diallo on Women and HIV (Video)

Barbara Jungwirth,; Posted Aug 28, 12:59 p.m. ET

Dázon Dixon Diallo, M.P.H., D.H.L., the founder of SisterLove, Inc., pronounced IAS 2015 "the moment where we can do away with the dichotomy of prevention [versus] treatment" because treatment is prevention. According to Diallo, the challenge now is to implement that insight and get everyone tested and onto the care track he or she needs. The question she is asking about the pre-exposure prophylaxis (PrEP) research presented is, "What does this mean for women; what does this mean for women outside the reproductive realm?" Diallo hopes that next year's IAS conference in Durban, South Africa, will herald a "prevention revolution."

This Week in HIV Research: Pediatric Rilpivirine; Party Drugs Play Poorly With Booster Drugs; HIV's Lengthening Family Tree; and More

Myles Helfand,; Posted Aug 28, 11:51 a.m. ET

Ebola. Hodgkin's lymphoma. Mother-to-child transmission. Sure, these might sound like old topics in HIV, but in the same way that the epidemic is ever-evolving, so is our understanding of many long-since identified facets of the epidemic.

My Health Tracker

My Health Tracker

My Health Tracker can help you organize your HIV treatment information privately and securely in one place. This way, you can take better charge over your health, and you and your doctor can have even more productive conversations about your treatment.

Registration takes only a couple of minutes, requires no personal info, and you'll be able to pick up where you left off at any time.


The Laws Used Against Increase Marginalized Communities' Vulnerability to HIV

Derek J. Demeri,; Posted Aug 28, 11:24 a.m. ET

"Displaced sex workers will have to make riskier decisions as they seek new ways to pay end-of-the-month bills such as rent," explains Derek Demeri of New Jersey Red Umbrella Alliance. "The leverage that many male sex workers felt they once had to negotiate condom use and other safer-sex practices has been increasingly eroded by the government's war on sex work."

From Cartoons to Charts, Learn About PrEP for HIV Prevention

Julie "JD" Davids,; Posted Aug 27, 4:32 p.m. ET

As more people consider pre-exposure prophylaxis (PrEP) for HIV prevention, the options for expanding knowledge about PrEP are, well, expanding. took a quick look at a handful of accessible resources for PrEP information and support.

An HIV-Positive Professional Discusses His Tumultuous Diagnosis and the Problem With Retention in Care

Mathew Rodriguez,; Posted Aug 27, 1:33 p.m. ET

Adam Thompson was dealing with a lot at the time of his diagnosis. In this interview, he goes through what finally got him into care.

Could Long-Acting Injectable Meds Soon Replace Daily Pills for HIV Maintenance Therapy?

Mathew Rodriguez,; Posted Aug 27, 1:32 p.m. ET

Long acting maintenance therapy for HIV-positive people with an undetectable viral load may soon be a reality. What does that mean and how will it work?

>> Browse Older Featured Stories


  • Email Email
  • Glossary Glossary